Impact BioMedical IBO Steady at 054 Awaiting Next Catalyst 20260520 Should You Sell Artelo ARTL After 634 Drop 20260521 IMRX Q1 2026 Earnings Narrowing Losses Drive Positive Surprise as Immuneering Advances Pipeline Palantir Faces Setback as UK Government Saves Millions by Dropping Its Refugee System Tech